Harrison SA - Search Results

1

Impact of obesity on treatment of chronic hepatitis C.

Charlton MR, Pockros PJ, Harrison SA. Charlton MR, et al. Among authors: harrison sa. Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239. Hepatology. 2006. PMID: 16729327 Review.

2

Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Harrison SA, Di Bisceglie AM. Harrison SA, et al. Drugs. 2003;63(22):2379-94. doi: 10.2165/00003495-200363220-00001. Drugs. 2003. PMID: 14609346 Review.

3

Steatosis and chronic hepatitis C infection: mechanisms and significance.

Harrison SA. Harrison SA. Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S92-6. doi: 10.1016/s1542-3565(05)00706-8. Clin Gastroenterol Hepatol. 2005. PMID: 16234070 Review.

4

Small molecule and novel treatments for chronic hepatitis C virus infection.

Harrison SA. Harrison SA. Am J Gastroenterol. 2007 Oct;102(10):2332-8. doi: 10.1111/j.1572-0241.2007.01397.x. Epub 2007 Jul 7. Am J Gastroenterol. 2007. PMID: 17617208 Review.

5

Insulin resistance in chronic hepatitis C, genotypes 1 and 4: the unfortunate reality.

Torres DM, Harrison SA. Torres DM, et al. Among authors: harrison sa. Hepatology. 2008 Jun;47(6):2137-9. doi: 10.1002/hep.22353. Hepatology. 2008. PMID: 18508298 No abstract available.

6

Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment.

Harrison SA. Harrison SA. Clin Gastroenterol Hepatol. 2008 Aug;6(8):864-76. doi: 10.1016/j.cgh.2008.03.024. Epub 2008 Jun 27. Clin Gastroenterol Hepatol. 2008. PMID: 18585970 Review.

7

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Harrison SA, et al. Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575. Hepatology. 2009. PMID: 19053049 Clinical Trial.

8

Diagnosis, management, and treatment of hepatitis C: an update.

Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Ghany MG, et al. Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759. Hepatology. 2009. PMID: 19330875 Free PMC article. No abstract available.

9

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Gastaldelli A, et al. Among authors: harrison sa. Hepatology. 2009 Oct;50(4):1087-93. doi: 10.1002/hep.23116. Hepatology. 2009. PMID: 19670459 Clinical Trial.

10

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Starley BQ, Calcagno CJ, Harrison SA. Starley BQ, et al. Among authors: harrison sa. Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Hepatology. 2010. PMID: 20432259 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page